TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
OptiBiotix Health ( (GB:OPTI) ) has issued an update.
OptiBiotix Health plc has raised £750,000 through a share placement to fund its expansion in the USA, including leasing a warehousing facility and manufacturing SlimBiome products to meet growing demand. The company has also established a new subsidiary, OptiBiotix Health USA, to strengthen its presence in the American market and reduce tariff risks. The funds will also support sales growth with existing and new partners, particularly in the USA, and increase awareness of its products on e-commerce platforms in India. This strategic move is expected to enhance OptiBiotix’s market positioning and drive profitability.
More about OptiBiotix Health
OptiBiotix Health plc, established in March 2012, operates in the life sciences industry, focusing on developing compounds that modify the human microbiome to prevent and manage diseases and promote wellness. The company is engaged in extensive R&D, collaborating with leading academics to create microbial strains and formulations used in active ingredients and supplements. OptiBiotix partners with over twenty international food and healthcare supplement companies to incorporate its microbiome modulators into various food products and drinks, with a focus on obesity, cardiovascular health, and diabetes.
Average Trading Volume: 269,277
Technical Sentiment Signal: Sell
Current Market Cap: £17.87M
For an in-depth examination of OPTI stock, go to TipRanks’ Stock Analysis page.